FREAMINE III 8.5% W/ ELECTROLYTES Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Freamine Iii 8.5% W/ Electrolytes, and what generic alternatives are available?
Freamine Iii 8.5% W/ Electrolytes is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in FREAMINE III 8.5% W/ ELECTROLYTES is amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate. There is one drug master file entry for this compound. Additional details are available on the amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FREAMINE III 8.5% W/ ELECTROLYTES?
- What are the global sales for FREAMINE III 8.5% W/ ELECTROLYTES?
- What is Average Wholesale Price for FREAMINE III 8.5% W/ ELECTROLYTES?
Summary for FREAMINE III 8.5% W/ ELECTROLYTES
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | FREAMINE III 8.5% W/ ELECTROLYTES at DailyMed |
US Patents and Regulatory Information for FREAMINE III 8.5% W/ ELECTROLYTES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | FREAMINE III 8.5% W/ ELECTROLYTES | amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate | INJECTABLE;INJECTION | 016822-007 | Jul 1, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
